{"DataElement":{"publicId":"2195606","version":"1","preferredName":"Common Toxicity Criteria Adverse Event Laryngeal Edema Grade","preferredDefinition":"in CTC category Pulmonary/Upper Respiratory, assessment of the severity of a larynx edema adverse event using a graded scale.","longName":"CTC_AE_LRYNGEALED_GD","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2195602","version":"1","preferredName":"Common Toxicity Criteria Adverse Event Laryngeal Edema","preferredDefinition":"information related to the CTC adverse event of larynx edema.","longName":"CTC_AE_LRYNGEALEDEMA","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2480706","version":"1","preferredName":"Common Terminology Criteria for Adverse Events","preferredDefinition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.","longName":"C49704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Common Terminology Criteria for Adverse Events","conceptCode":"C49704","definition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"133A63CA-49B0-49FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-07","modifiedBy":"ONEDATA","dateModified":"2006-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2195600","version":"1","preferredName":"Laryngeal oedema","preferredDefinition":"Edema of any region of the larynx from a variety of causes. In the earliest stages it may be difficult to differentiate from infection, although mucosal injection and erythema are found more often in the latter. Allergic edema may result as a response from provocation induced by foods, inhalants, and drugs. The entire respiratory tract or only an isolated portion of the larynx may be affected. Laryngeal edema may also be hereditary. Other possible causes of laryngeal edema include increased capillary pressure due to superior vena cava syndrome, internal jugular vein ligation, lowered plasma osmotic failure induced by renal failure, impaired lymphatic flow, and increased capillary permeability to proteins. (From Paparella et al., Otolaryngology, 3d ed, p2253)","longName":"Laryngeal oedema","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Laryngeal oedema","conceptCode":"C0023052","definition":"Edema of any region of the larynx from a variety of causes. In the earliest stages it may be difficult to differentiate from infection, although mucosal injection and erythema are found more often in the latter. Allergic edema may result as a response from provocation induced by foods, inhalants, and drugs. The entire respiratory tract or only an isolated portion of the larynx may be affected. Laryngeal edema may also be hereditary. Other possible causes of laryngeal edema include increased capillary pressure due to superior vena cava syndrome, internal jugular vein ligation, lowered plasma osmotic failure induced by renal failure, impaired lymphatic flow, and increased capillary permeability to proteins. (From Paparella et al., Otolaryngology, 3d ed, p2253)","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED905F00-39A0-602A-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-13","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED905F00-39A6-602A-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-13","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2195605","version":"1","preferredName":"Common Toxicity Criteria Adverse Event Laryngeal Edema Grade","preferredDefinition":"in CTC category Pulmonary/Upper Respiratory, assessment of the severity of a larynx edema adverse event using a graded scale.","longName":"CTC_AE_LRYNGEALED_GD","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"0","valueDescription":"None at all","ValueMeaning":{"publicId":"2574138","version":"1","preferredName":"None at all","longName":"2574138","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EEA7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CLOHNES","dateModified":"2022-08-12","changeDescription":null,"administrativeNotes":"8/12/22 added alt VM for Alliance cjl;","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED9238B6-C8B7-256D-E034-0003BA3F9857","beginDate":"2004-08-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-13","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"2","valueDescription":"Symptomatic edema, no respiratory distress","ValueMeaning":{"publicId":"2572817","version":"1","preferredName":"Symptomatic edema, no respiratory distress","longName":"2572817","preferredDefinition":"Symptomatic edema, no respiratory distress","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E97E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-13","modifiedBy":"SHIDED","dateModified":"2005-01-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED9238B6-C8BE-256D-E034-0003BA3F9857","beginDate":"2005-01-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-13","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"3","valueDescription":"Stridor; respiratory distress; interfering with ADL","ValueMeaning":{"publicId":"2572818","version":"1","preferredName":"Stridor; respiratory distress; interfering with ADL","longName":"2572818","preferredDefinition":"Stridor; respiratory distress; interfering with ADL","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E97F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-13","modifiedBy":"SHIDED","dateModified":"2005-01-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED9238B6-C8C2-256D-E034-0003BA3F9857","beginDate":"2005-01-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-13","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"4","valueDescription":"Life-threatening airway compromise; tracheotomy, intubation, or laryngectomy indicated","ValueMeaning":{"publicId":"2572819","version":"1","preferredName":"Life-threatening airway compromise; tracheotomy, intubation, or laryngectomy indicated","longName":"2572819","preferredDefinition":"Life-threatening airway compromise; tracheotomy, intubation, or laryngectomy indicated","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E980-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-13","modifiedBy":"SHIDED","dateModified":"2005-01-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED9238B6-C8C6-256D-E034-0003BA3F9857","beginDate":"2005-01-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-13","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"5","valueDescription":"Death","ValueMeaning":{"publicId":"2567604","version":"1","preferredName":"Death","longName":"2567604","preferredDefinition":"The cessation of life.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dead","conceptCode":"C28554","definition":"The cessation of life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D521-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"COOPERM","dateModified":"2015-11-24","changeDescription":"Added the NCIt concept definition as the System Generated definition per request by NMDP. mc 11/24/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED9238B6-C8C9-256D-E034-0003BA3F9857","beginDate":"2002-10-11","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-13","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"1","valueDescription":"Asymptomatic edema by exam only","ValueMeaning":{"publicId":"2572816","version":"1","preferredName":"Asymptomatic edema by exam only","longName":"2572816","preferredDefinition":"Asymptomatic edema by exam only","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E97D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-13","modifiedBy":"SHIDED","dateModified":"2005-01-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED9238B6-C8BA-256D-E034-0003BA3F9857","beginDate":"2005-01-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-13","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184299","version":"1","preferredName":"Grade","preferredDefinition":"Describes how closely a cancer resembles normal tissue of its same type, and the cancer's probable rate of growth","longName":"Grade","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-1C87-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED915054-1EBC-00A1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-13","modifiedBy":"REEVESD","dateModified":"2014-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2812032","version":"1","longName":"Common Terminology Criteria for Adverse Events v3.0","context":"CTEP"}]},{"publicId":"2604617","version":"1","longName":"Submission and Reporting","context":"CTEP","ClassificationSchemeItems":[{"publicId":"10000132","version":"1","longName":"Common Terminology Criteria for Adverse Events v3.0","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"CTC Adverse Event Edema, lary","type":"Preferred Question Text","description":"CTC Adverse Event Edema, larynx Grade","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Edema, larynx Grade","url":null,"context":"CTEP"},{"name":"Source","type":"DATA_ELEMENT_SOURCE","description":"Data element and all values comply with Common Terminology Criteria for Adverse Events v3.0 (CTCAE)","url":"http://ctep.cancer.gov/reporting/ctc.html","context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"ED915054-1ED3-00A1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-13","modifiedBy":"REEVESD","dateModified":"2011-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}